In our proof‐of‐principle study using the CCl4‐induced experimental mouse model of chronic liver damage, we showed that repeated intrahepatic administrations of Ad‐IL10 mixed with CMC effectively alleviated the development of hepatic fibrosis. This evidence concerns the gene IL10 and Hepatic fibrosis.